Search
The U.S. Supreme Court justices today said they will hear a challenge to Myriad Genetics Inc.’s patents on genetic material used in tests for breast and ovarian cancer.

Photographer: Chip Somodevilla/Getty Images

The U.S. Supreme Court justices today said they will hear a challenge to Myriad Genetics Inc.’s patents on genetic material used in tests for breast and ovarian cancer.
December 01, 2012
Article
Gene Patents Draw High Court Review in Biotechnology Test
« Back to Home